Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

1,422 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,422 results

Testing effectiveness (Phase 2)Looking for participantsNCT06807606
What this trial is testing

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT03718533
What this trial is testing

Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function

Who this might be right for
Poor Graft Function
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Looking for participantsNCT06812858
What this trial is testing

PD-1 Inhibitors Maintenance for cHL Post-autoHCT

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 83
Early research (Phase 1)Study completedNCT02611063
What this trial is testing

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Stefanie Sarantopoulos, MD, PhD. 22
Not applicableEnded earlyNCT01517347
What this trial is testing

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 90
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752
What this trial is testing

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia
Shanghai Jiao Tong University School of Medicine 20
Not applicableStudy completedNCT00889278
What this trial is testing

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Who this might be right for
Lymphoma
Dartmouth-Hitchcock Medical Center 30
Not applicableUnknownNCT03704597
What this trial is testing

Cryotherapy Against Oral Mucositis After High-dose Melphalan

Who this might be right for
MyelomaMucositisCryotherapy Effect
Sahlgrenska University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00797758
What this trial is testing

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Early research (Phase 1)Active Not RecruitingNCT02477878
What this trial is testing

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphoma+2 more
Bellicum Pharmaceuticals 10
Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Early research (Phase 1)Active Not RecruitingNCT02050347
What this trial is testing

Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)

Who this might be right for
Non-Hodgkin's LymphomaB-Cell ALLB-Cell CLL
Baylor College of Medicine 7
Testing effectiveness (Phase 2)UnknownNCT04692376
What this trial is testing

MSC for Treatment of cGVHD After Allo-HSCT

Who this might be right for
Chronic Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 152
Not applicableLooking for participantsNCT07285668
What this trial is testing

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Wisconsin, Madison 38
Testing effectiveness (Phase 2)Study completedNCT01309997
What this trial is testing

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host DiseaseSystemic Scleroderma
Lee, Stephanie 72
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Testing effectiveness (Phase 2)UnknownNCT01002703
What this trial is testing

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leipzig 50
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010
What this trial is testing

Menin-Inhibitor Targeted Maintenance in AML

Who this might be right for
Relapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
Center for International Blood and Marrow Transplant Research 146
Next Page